Streetbeat News

Stock Prices

DJT

Trump Media & Technology Group Corp. (NASDAQ:DJT) continues to decline in premarket trading after a significant drop on Monday. The company reported a Q2 loss of $16.4 million and revenue of $837,000. Trump's return to X and the faltering metrics of Truth Social are contributing to the stock's downward pressure.

Portfolio Pulse from Shanthi Rexaline

August 13, 2024 | 12:27 pm

SPRY

ARS Pharmaceuticals shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $18 to $22.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:25 pm

EVOK

Evoke Pharma (NASDAQ:EVOK) reported Q2 earnings per share (EPS) of $(0.93), significantly missing the analyst estimate of $(0.06). The company also reported quarterly sales of $2.55 million, which fell short of the $2.98 million estimate. Despite the misses, sales increased by 125.58% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:23 pm

BTM

Bitcoin Depot (NASDAQ:BTM) reported Q2 sales of $163.10 million, beating the analyst consensus estimate of $149.30 million by 9.24%. However, this represents a 17.41% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:23 pm

DARE

Daré Bioscience announced the publication of findings from the Phase 2b RESPOND clinical study of Sildenafil Cream, 3.6% in The Journal of Sexual Medicine. The study supports the use of either 1-month or 24-hour recall patient-reported outcome instruments for assessing treatment efficacy, which may improve data collection compliance.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:22 pm

BIVI

BioVie Inc. (NASDAQ:BIVI) will present clinical data on Bezisterim at the 11th Aging Research and Drug Discovery Meeting in Copenhagen, Denmark, from August 26-30, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:21 pm

OCUP

Ocuphire Pharma (NASDAQ:OCUP) reported Q2 earnings per share (EPS) of $(0.30), missing the analyst consensus estimate of $(0.24) by 25%. The company also reported quarterly sales of $1.11 million, which missed the estimate of $2.61 million by 57.39%. Both EPS and sales figures represent significant declines compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:20 pm

CMG

Chipotle Mexican Grill shares are trading lower after the company announced that Chairman and CEO Brian Niccol will be leaving the company.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:19 pm

ARTL

Artelo Biosciences (NASDAQ:ARTL) reported a Q2 EPS of $(0.75), beating the analyst estimate of $(0.85) by 11.76%. This represents a 33.93% increase in losses compared to $(0.56) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:19 pm

PALI

Palisade Bio (NASDAQ:PALI) reported a Q2 2024 GAAP EPS of $(3.32), missing the analyst consensus estimate of $(3.11) by 6.75%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:18 pm